Non-communicable diseases pandemic and precision medicine: Is Africa ready?
- PMID: 33639396
- PMCID: PMC7921515
- DOI: 10.1016/j.ebiom.2021.103260
Non-communicable diseases pandemic and precision medicine: Is Africa ready?
Abstract
Non-communicable diseases (NCDs) kill more than 41 million people every year, accounting for 71% of all deaths globally. The prevalence of NCDs is estimated to be higher than that of infectious diseases in Africa by 2030. Precision medicine may help with early identification of cases, resulting in timely prevention and improvement in the efficacy of treatments. However, Africa has been lagging behind in genetic research, a key component of the precision medicine initiative. A number of genomic research initiatives which could lead to translational genomics are emerging on the African continent which includes the Non-communicable Diseases Genetic Heritage Study (NCDGHS) and the Men of African Descent and Carcinoma of the Prostate (MADCaP) Network. These offer a promise that precision medicine can be applied in African countries. This review evaluates the advances of genetic studies for cancer, hypertension, type 2 diabetes and body mass index (BMI) in Africa.
Keywords: Africa; Cancer; Diabetes; Genetics; Hypertension; Obesity.
Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Interests We have none to declare.
Figures
References
-
- Bigna JJ, Noubiap JJ. The rising burden of non-communicable diseases in sub-Saharan Africa. Lancet Global Health. 2019;7(10):e1295–e12e6. - PubMed
-
- Parkin DM, Bray F, Ferlay J, Jemal A. Cancer in Africa 2012. Cancer Epidemiol Biomarkers Prev. 2014;23(6):953–966. - PubMed
-
- Arena R, Ozemek C, Laddu D. Applying precision medicine to healthy living for the prevention and treatment of cardiovascular disease. Curr Probl Cardiol. 2018;43(12):448–483. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
